Cited by 1,000Neuroendocrine Tumor Research AdvancesPancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Whole-genome landscape of pancreatic neuroendocrine tumours

Australian Pancreatic Cancer Genome Initiative, Scarpa, Aldo, Chang, David K., Nones, Katia, Corbo, Vincenzo, Patch, Ann-Marie, Bailey, Peter, Lawlor, Rita T., Johns, Amber L., Miller, David K., Mafficini, Andrea, Rusev, Borislav, Scardoni, Maria, Antonello, Davide, Barbi, Stefano, Sikora, Katarzyna O., Cingarlini, Sara, Vicentini, Caterina, McKay, Skye, Quinn, Michael C. J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, McLean, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Wilson, Peter J., Anderson, Matthew J., Fink, J. Lynn, Newell, Felicity, Waddell, Nick, Holmes, Oliver, Kazakoff, Stephen H., Leonard, Conrad, Wood, Scott, Xu, Qinying, Nagaraj, Shivashankar Hiriyur, Amato, Eliana, Dalai, Irene, Bersani, Samantha, Cataldo, Ivana, Dei Tos, Angelo P., Capelli, Paola, Davì, Maria Vittoria, Landoni, Luca, Malpaga, Anna, Miotto, Marco, Whitehall, Vicki L. J., Leggett, Barbara A., Harris, Janelle L., Harris, Jonathan, Jones, Marc D., Humphris, Jeremy, Chantrill, Lorraine A., Chin, Venessa, Nagrial, Adnan M., Pajic, Marina, Scarlett, Christopher J., Pinho, Andreia, Rooman, Ilse, Toon, Christopher, Wu, Jianmin, Pinese, Mark, Cowley, Mark, Barbour, Andrew, Mawson, Amanda, Humphrey, Emily S., Colvin, Emily K., Chou, Angela, Lovell, Jessica A., Jamieson, Nigel B., Duthie, Fraser, Gingras, Marie-Claude, Fisher, William E., Dagg, Rebecca A., Lau, Loretta M. S., Lee, Michael, Pickett, Hilda A., Reddel, Roger R., Samra, Jaswinder S., Kench, James G., Merrett, Neil D., Epari, Krishna, Nguyen, Nam Q., Zeps, Nikolajs, Falconi, Massimo, Simbolo, Michele, Butturini, Giovanni, Van Buren, George, Partelli, Stefano, Fassan, Matteo, Khanna, Kum Kum, Gill, Anthony J., Wheeler, David A., Gibbs, Richard A., Musgrove, Elizabeth A., Bassi, Claudio, Tortora, Giampaolo, Pederzoli, Paolo, Pearson, John V., Waddell, Nicola, Biankin, Andrew V., Grimmond, Sean M.·2017·Nature

DOI 10.1038/nature21063

Open this paper in CoChat — free account

Abstract

The diagnosis of pancreatic neuroendocrine tumours (PanNETs) is increasing owing to more sensitive detection methods, and this increase is creating challenges for clinical management. We performed whole-genome sequencing of 102 primary PanNETs and defined the genomic events that characterize their pathogenesis. Here we describe the mutational signatures they harbour, including a deficiency in G:C > T:A base excision repair due to inactivation of MUTYH, which encodes a DNA glycosylase. Clinically sporadic PanNETs contain a larger-than-expected proportion of germline mutations, including previously unreported mutations in the DNA repair genes MUTYH, CHEK2 and BRCA2. Together with mutations in MEN1 and VHL, these mutations occur in 17% of patients. Somatic mutations, including point mutations and gene fusions, were commonly found in genes involved in four main pathways: chromatin remodelling, DNA damage repair, activation of mTOR signalling (including previously undescribed EWSR1 gene fusions), and telomere maintenance. In addition, our gene expression analyses identified a subgroup of tumours associated with hypoxia and HIF signalling.

Integrity signals

Registry

Crossref · 10.1038/nature21063

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citation
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Self-citation
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Mermel, C. H., Schumacher, S. E., Hill, B., Meyerson, M. M., Beroukhim, R., & Getz, G. A. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-r41 · Cited by 3,520
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
Whole genomes redefine the mutational landscape of pancreatic cancer
Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642
Self-citation
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., et al. (2016) · Nature · doi:10.1038/nature17676 · Cited by 2,218
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058
Self-citation
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,744
Whole–genome characterization of chemoresistant ovarian cancer
Patch, A., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P. A., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,572
Self-citation
Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field
Krieger, E., Koraimann, G., & Vriend, G. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10104 · Cited by 1,521
Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks
Alers, S., Löffler, A. S., Wesselborg, S., & Stork, B. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06159-11 · Cited by 1,483
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Tassan, N. A. A., Chmiel, N. H., Maynard, J. H., Fleming, N. I., Livingston, A. L., Williams, G. T., Hodges, A., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,412
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Heaphy, C. M., de Wilde, R. F., Jiao, Y., Klein, A. P., Edil, B. H., Shi, C., Bettegowda, C., Rodriguez, F. J., Eberhart, C. G., Hebbar, S., et al. (2011) · Science · doi:10.1126/science.1207313 · Cited by 1,083
A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Sturm, D., Orr, B. A., Toprak, U. H., Hovestadt, V., Jones, D., Capper, D., Sill, M., Buchhalter, I., Northcott, P. A., Irina, L., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.015 · Cited by 991
Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629
Self-citation
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
Tirode, F., Surdez, D., Ma, X., Parker, M. D., Deley, M. L., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 594
The Genomic Landscape of Pediatric Ewing Sarcoma
Crompton, B. D., Stewart, C., Taylor-Weiner, A. N., Alexe, G., Kurek, K. C., Calicchio, M. L., Kieżun, A., Carter, S. L., Shukla, S. A., Mehta, S. S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1037 · Cited by 592
IntOGen-mutations identifies cancer drivers across tumor types
González-Pérez, A., Perez-Llamas, C., Deu-Pons, J., Tamborero, D., Schroeder, M. P., Jené-Sanz, A., Santos, A., & López-Bigas, N. (2013) · Nature Methods · doi:10.1038/nmeth.2642 · Cited by 586
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.
May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman‐Rossi, J., Thomas, G. D., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 576
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Missiaglia, E., Dalai, I., Barbi, S., Beghelli, S., Falconi, M., Peruta, M. D., Piemonti, L., Capurso, G., Florio, A. D., Fave, G. D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5988 · Cited by 535
Self-citation
A quantitative PCR method for measuring absolute telomere length
O’Callaghan, N. J., & Fenech, M. F. (2011) · Biological Procedures Online · doi:10.1186/1480-9222-13-3 · Cited by 490
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Marinoni, I., Kurrer, A. M. S., Vassella, E., Dettmer, M. S., Rudolph, T. J., Banz, V. M., Hunger, F., Pasquinelli, S., Speel, E. M., & Perren, A. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.020 · Cited by 473
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
Brohl, A. S., Solomon, D. A., Chang, W., Wang, J., Song, Y., Sindiri, S., Patidar, R., Hurd, L., Chen, L., Shern, J. F., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004475 · Cited by 440
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Lin, S., & Elledge, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00430-6 · Cited by 432
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Francis, J. M., Kieżun, A., Ramos, A. H., Serra, S., Pedamallu, C. S., Qian, Z. R., Banck, M. S., Kanwar, R., Kulkarni, A. A., Karpathakis, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2821 · Cited by 373
Expanded Extracolonic Tumor Spectrum in MUTYH-Associated Polyposis
Vogt, S. L., Jones, N., Christian, D., Engel, C., Nielsen, M., Kaufmann, A., Steinke, V., Vasen, H. F. A., Propping, P., Sampson, J. R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.052 · Cited by 347
Mutations in CHEK2 Associated with Prostate Cancer Risk
Dong, X., Wang, L., Taniguchi, K., Wang, X., Cunningham, J. M., McDonnell, S. K., Qian, C., Marks, A. F., Slager, S. L., Peterson, B. J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/346094 · Cited by 313
Menin: a scaffold protein that controls gene expression and cell signaling
Matkar, S. S., Thiel, A. T., & Hua, X. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.05.005 · Cited by 295
Germline CDKN1B/p27Kip1 Mutation in Multiple Endocrine Neoplasia
Georgitsi, M., Raitila, A., Karhu, A., van der Luijt, R. B., Aalfs, C. M., Sane, T., Kuismin, O., Mäkinen, M. J., Tuppurainen, K., Paschke, R., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2843 · Cited by 283
Promiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 273
Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis
Nones, K., Waddell, N., Wayte, N., Patch, A., Bailey, P. J., Newell, F., Holmes, O., Fink, J. L., Quinn, M. C. J., Tang, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6224 · Cited by 266
Self-citation
Multiple Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease Patients
Lubensky, I. A., Pack, S., Ault, D. O., Vortmeyer, A. O., Libutti, S. K., Choyke, P. L., Walther, M. M., Linehan, W. M., & Zhuang, Z. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65563-0 · Cited by 258
EWSR1-CREB1 and EWSR1-ATF1 Fusion Genes in Angiomatoid Fibrous Histiocytoma
Rossi, S., Szuhai, K., IJszenga, M. J., Tanke, H. J., Zanatta, L., Sciot, R., Fletcher, C. D. �., Tos, A. P. D., & Hogendoorn, P. C. W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1744 · Cited by 231
Malignant Gastrointestinal Neuroectodermal Tumor
Stockman, D. L., Miettinen, M., Suster, S. M., Spagnolo, D. V., Domínguez-Malagón, H. R., Hornick, J. L., Adsay, V. N., Chou, P. M., Amanuel, B., vanTuinen, P., et al. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31824644ac · Cited by 223
A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
Sadanandam, A., Wullschleger, S., Lyssiotis, C. A., Grötzinger, C., Barbi, S., Bersani, S., Körner, J., Wafy, I., Mafficini, A., Lawlor, R. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0068 · Cited by 212
Self-citation
Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays
Popova, T. G., Manié, É., Stoppa‐Lyonnet, D., Rigaill, G. J., Barillot, E., & Stern, M. (2009) · Genome biology · doi:10.1186/gb-2009-10-11-r128 · Cited by 199
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Cai, Z., Chehab, N. H., & Pavletich, N. P. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.007 · Cited by 193
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases
Corbo, V., Dalai, I., Scardoni, M., Barbi, S., Beghelli, S., Bersani, S., Albarello, L., Doglioni, C., Schott, C., Capelli, P., et al. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0028 · Cited by 167
Self-citation
The Tumor Suppressor Protein Menin Inhibits AKT Activation by Regulating Its Cellular Localization
Wang, Y., Ozawa, A., Zaman, S., Prasad, N. B., Chandrasekharappa, S. C., Agarwal, S. K., & Marx, S. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-3221 · Cited by 116
qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
Song, S., Nones, K., Miller, D. K., Harliwong, I., Kassahn, K. S., Pinese, M., Pajic, M., Gill, A. J., Johns, A. L., Anderson, M. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045835 · Cited by 112
Self-citation
Human Glial Cell Line-derived Neurotrophic Factor Receptor α4 Is the Receptor for Persephin and Is Predominantly Expressed in Normal and Malignant Thyroid Medullary Cells
Lindahl, M., Poteryaev, D. A., Yu, L.-Y., Arumäe, U., Timmusk, T., Bongarzone, I., Aiello, A., Pierotti, M. A., Airaksinen, M. S., & Saarma, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008279200 · Cited by 106
The `dnet¿ approach promotes emerging research on cancer patient survival
Fang, H., & Gough, J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0064-8 · Cited by 98
Differentiating Ewing's sarcoma from other round blue cell tumors using a RT-PCR translocation panel on formalin-fixed paraffin-embedded tissues
Lewis, T. B., Coffin, C. M., & Bernard, P. S. (2007) · Modern Pathology · doi:10.1038/modpathol.3800755 · Cited by 96
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
Bell, D. W., Kim, S. H., Godwin, A. K., Schiripo, T. A., Harris, P. L., Haserlat, S. M., Wahrer, D. C. R., Haiman, C. A., Daly, M. B., Niendorf, K. B., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23026 · Cited by 90
New Epigenetic Drivers of Cancers
Elsässer, S. J., Allis, C. D., & Lewis, P. W. (2011) · Science · doi:10.1126/science.1203280 · Cited by 84
Role of inherited defects of MYH in the development of sporadic colorectal cancer
Kambara, T., Whitehall, V., Spring, K. J., Barker, M., Arnold, S., Wynter, C. V. A., Matsubara, N., Tanaka, N., Young, J. P., Leggett, B., et al. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20011 · Cited by 79
Self-citation
Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells
Li, B. E., Gan, T., Meyerson, M. M., Rabbitts, T. H., & Ernst, P. (2013) · Blood · doi:10.1182/blood-2013-03-486647 · Cited by 67
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events
Aretz, S., Tricarico, R., Papi, L., Spier, I., Pin, E., Horpaopan, S., Cordisco, E. L., Pedroni, M., Stienen, D., Gentile, A., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.309 · Cited by 59
MEN1 Is a Melanoma Tumor Suppressor That Preserves Genomic Integrity by Stimulating Transcription of Genes That Promote Homologous Recombination-Directed DNA Repair
Fang, M., Xia, F., Mahalingam, M., Virbasius, C.-M. A., Wajapeyee, N., & Green, M. R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00167-13 · Cited by 57
The Malignant Brain Tumor (MBT) Domain Protein SFMBT1 Is an Integral Histone Reader Subunit of the LSD1 Demethylase Complex for Chromatin Association and Epithelial-to-mesenchymal Transition
Tang, M., Shen, H., Jin, Y., Lin, T., Cai, Q., Pinard, M. A., Biswas, S., Tran, Q., Li, G., Shenoy, A. K., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482349 · Cited by 46
Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase‐mitogen‐activated protein kinase signaling pathway
Baba, T., Sakamoto, Y., Kasamatsu, A., Minakawa, Y., Yokota, S., Higo, M., Yokoe, H., Ogawara, K., Shiiba, M., Tanzawa, H., et al. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22127 · Cited by 35
Mutation-targeted therapy with sunitinib or everolimus in patients with advanced low-grade or intermediate-grade neuroendocrine tumours of the gastrointestinal tract and pancreas with or without cytoreductive surgery: protocol for a phase II clinical trial
Neychev, V. K., Steinberg, S. M., Cottle‐Delisle, C., Merkel, R., Nilubol, N., Yao, J., Meltzer, P. S., Pacák, K., Marx, S. J., & Kebebew, E. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008248 · Cited by 33
High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas
Asai, A., Karnan, S., Ota, A., Takahashi, M., Damdindorj, L., Konishi, Y., Hossain, E., Konishi, H., Nagata, A., Yokoo, K., et al. (2015) · Gene · doi:10.1016/j.gene.2014.12.064 · Cited by 16

Flagged first, then by citations

Sorted by citations

Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Self-citation
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pavel, M. E., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A. A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,191
Self-citation
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Rindi, G., Klimstra, D. S., Abedi‐Ardekani, B., Asa, S. L., Bosman, F. T., Brambilla, E. M., BUSAM, K. J., de Krijger, R. R., Dietel, M., El‐Naggar, A. K., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0110-y · Cited by 1,164
Self-citation
Comprehensive Analysis of Hypermutation in Human Cancer
Campbell, B. B., Light, N. D., Fabrizio, D. A., Zatzman, M., Fuligni, F., de Borja, R., Davidson, S., Edwards, M., Elvin, J. A., Hodel, K. P., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.048 · Cited by 778
“Importantly, a similar approach may lead to novel insights and clinical applications in other DNA repair genes, especially for those with a unique signature (Scarpa et al., 2017).”
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P. M., Alitalo, K. K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., B, J. R. V. B., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 619

See all 1,000

Authors: Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., Mafficini, A., Rusev, B., Scardoni, M., Antonello, D., Barbi, S., Sikora, K. O., Cingarlini, S., Vicentini, C., McKay, S., Quinn, M. C. J., Bruxner, T. J. C., Christ, A. N., Harliwong, I., Idrisoglu, S., McLean, S., Nourse, C., Nourbakhsh, E., Wilson, P. J., Anderson, M. J., Fink, J. L., Newell, F., Waddell, N., Holmes, O., Kazakoff, S. H., Leonard, C., Wood, S., Xu, Q., Nagaraj, S. H., Amato, E., Dalai, I., Bersani, S., Cataldo, I., Dei Tos, A. P., Capelli, P., Davì, M. V., Landoni, L., Malpaga, A., Miotto, M., Whitehall, V. L. J., Leggett, B. A., Harris, J. L., Harris, J., Jones, M. D., Humphris, J., Chantrill, L. A., Chin, V., Nagrial, A. M., Pajic, M., Scarlett, C. J., Pinho, A., Rooman, I., Toon, C., Wu, J., Pinese, M., Cowley, M., Barbour, A., Mawson, A., Humphrey, E. S., Colvin, E. K., Chou, A., Lovell, J. A., Jamieson, N. B., Duthie, F., Gingras, M.-C., Fisher, W. E., Dagg, R. A., Lau, L. M. S., Lee, M., Pickett, H. A., Reddel, R. R., Samra, J. S., Kench, J. G., Merrett, N. D., Epari, K., Nguyen, N. Q., Zeps, N., Falconi, M., Simbolo, M., Butturini, G., Van Buren, G., Partelli, S., Fassan, M., Khanna, K. K., Gill, A. J., Wheeler, D. A., Gibbs, R. A., Musgrove, E. A., Bassi, C., Tortora, G., Pederzoli, P., Pearson, J. V., Waddell, N., Biankin, A. V., & Grimmond, S. M.
Affiliations: University of Verona (IT)
Garvan Institute of Medical Research (AU)
The University of Queensland (AU)
Queensland University of Technology (AU)
Glasgow Royal Infirmary (GB)
Baylor College of Medicine (US)
Children's Hospital at Westmead (AU)
The University of Sydney (AU)
Fremantle Hospital (AU)
Royal Adelaide Hospital (AU)
The University of Melbourne (AU)
Corresponding author: Scarpa, Aldo
Biankin, Andrew V.
Grimmond, Sean M.
ORCID: Scarpa, Aldo
Chang, David K.
Corbo, Vincenzo
Patch, Ann-Marie
Bailey, Peter
Lawlor, Rita T.
Johns, Amber L.
Mafficini, Andrea
Rusev, Borislav
Antonello, Davide
Barbi, Stefano
Cingarlini, Sara
Vicentini, Caterina
Quinn, Michael C. J.
Bruxner, Timothy J. C.
Christ, Angelika N.
Harliwong, Ivon
Nourbakhsh, Ehsan
Wilson, Peter J.
Anderson, Matthew J.
Fink, J. Lynn
Newell, Felicity
Holmes, Oliver
Kazakoff, Stephen H.
Leonard, Conrad
Wood, Scott
Nagaraj, Shivashankar Hiriyur
Bersani, Samantha
Cataldo, Ivana
Davì, Maria Vittoria
Landoni, Luca
Malpaga, Anna
Miotto, Marco
Whitehall, Vicki L. J.
Leggett, Barbara A.
Harris, Jonathan
Jones, Marc D.
Chantrill, Lorraine A.
Chin, Venessa
Nagrial, Adnan M.
Pajic, Marina
Scarlett, Christopher J.
Pinho, Andreia
Rooman, Ilse
Toon, Christopher
Wu, Jianmin
Pinese, Mark
Cowley, Mark
Barbour, Andrew
Mawson, Amanda
Colvin, Emily K.
Chou, Angela
Jamieson, Nigel B.
Gingras, Marie-Claude
Dagg, Rebecca A.
Lau, Loretta M. S.
Lee, Michael
Pickett, Hilda A.
Reddel, Roger R.
Samra, Jaswinder S.
Kench, James G.
Merrett, Neil D.
Nguyen, Nam Q.
Zeps, Nikolajs
Falconi, Massimo
Simbolo, Michele
Partelli, Stefano
Fassan, Matteo
Khanna, Kum Kum
Gill, Anthony J.
Wheeler, David A.
Gibbs, Richard A.
Bassi, Claudio
Tortora, Giampaolo
Pearson, John V.
Waddell, Nicola
Biankin, Andrew V.
Grimmond, Sean M.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2017-02-15
Volume: 543
Issue: 7643
Pages: 65-71
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature21063
OpenAlex: W2589112207
Cited by: 999
References: 62
Citations by year: 2026: 65 · 2025: 101 · 2024: 103 · 2023: 110 · 2022: 126 · 2021: 108 · 2020: 131 · 2019: 89 · 2018: 103 · 2017: 52
FWCI: 81.15
Type: journal article
Language: en
Update notices: erratum (2017-09-27)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
QUT ePrints (Queensland University of Technology) (submittedVersion)
UWA Profiles and Research Repository (UWA) (submittedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
NOVA (University of Newcastle Australia) (submittedVersion)
VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Padua Research Archive (University of Padova) (submittedVersion)
Funders: Pancreatic Cancer UK (RIF2015_A06_Jamieson, FLF2015_04_GLASGOW)
Wellcome Trust (103721/Z/14/Z)
Cancer Research UK (23526, 17263, 22533)
Academy of Medical Sciences (AMS-SGCL9-Jamieson)
Medical Research Council (MR/N005813/1)
Topics: Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords: pancreatic neuroendocrine tumors, mutational signatures, MUTYH, germline mutations, CHEK2, BRCA2, MEN1, VHL, chromatin remodeling, DNA repair, mTOR signaling, telomere maintenance, hypoxia, carcinogenesis
MeSH terms: Base Sequence, Calmodulin-Binding Proteins, Chromosome Aberrations, DNA Mutational Analysis, DNA Repair, Female, Humans, Male, Pancreatic Neoplasms, Genome, Human, RNA-Binding Proteins, Telomere, Germ-Line Mutation, Carcinoma, Neuroendocrine, Genomics, RNA-Binding Protein EWS, Chromatin Assembly and Disassembly, DNA Glycosylases, DNA Copy Number Variations, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Whole-genome landscape of pancreatic neuroendocrine tumours

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks